Results 41 to 50 of about 11,464,348 (142)

Combined Application of a Helix‐Fixation Leadless Pacemaker and a Subcutaneous Implantable Cardioverter‐Defibrillator in a Dialysis Patient: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Combined use of S‐ICD and LP provides an effective alternative for patients requiring defibrillation and pacing while avoiding transvenous leads. This strategy is particularly valuable for patients with a high risk of infection, though careful consideration must be given to minimizing potential device–device interactions.
ZhaoWei Zhou   +3 more
wiley   +1 more source

Two undesired conditions resulting from T-Wave oversensing in two patients with hypertrophic cardiomyopathy: Inappropriate ICD shocks and pacemaker dysfunction

open access: yesResearch in Cardiovascular Medicine, 2017
Introduction: T-wave oversensing (TWOS) is generally seen in patients with hypertrophic cardiomyopathy (HCM) and is a rare cause of inappropriate implantable cardioverter defibrillator (ICD) shocks. TWOS rarely causes pacemaker dysfunction.
Filiz Kizilirmak   +4 more
doaj   +1 more source

Midterm Efficacy of SubcutAneous Implantable CardioVErter‐Defibrillator in ≤ 18 Year‐Old CHILDREN (SAVE CHILDREN‐II Registry)

open access: yesJournal of Arrhythmia, Volume 42, Issue 4, August 2026.
S‐ICD therapy demonstrated favorable mid‐term safety and efficacy in pediatric patients, with durable sensing performance and a low incidence of device‐related infection. ABSTRACT Background The subcutaneous implantable cardioverter‐defibrillator (S‐ICD) avoids transvenous leads and is a promising option for sudden cardiac death (SCD) prevention in ...
Hitoshi Mori   +76 more
wiley   +1 more source

Inappropriate shocks from a subcutaneous implantable cardioverter-defibrillator due to oversensing during periods of rate-related bundle branch block

open access: yesJournal of Arrhythmia, 2017
The subcutaneous implantable cardioverter-defibrillator (S-ICD) is a novel technology with proven efficacy in sudden cardiac death prevention; however, there is a lack of long-term safety data.
Maria João Sousa, MD, Tim Betts, MD
doaj   +1 more source

Trajectory‐specific motion‐induced electromotive force assessment of pacemaker‐carrying workers in MRI environments

open access: yesMedical Physics, Volume 53, Issue 7, July 2026.
Abstract Purpose Motion of individuals carrying active implantable medical devices (AIMDs), such as pacemakers (PMs) and implantable cardioverter defibrillators (ICDs), within the spatially varying static magnetic field in and around magnetic resonance imaging (MRI) systems can induce electromotive forces (EMFs) in conductive leads.
Valentina Hartwig   +5 more
wiley   +1 more source

Initial experience with the subcutaneous implantable cardioverter-defibrillator in a single Japanese center

open access: yesJournal of Arrhythmia, 2017
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is recognized as a viable alternative to the transvenous ICD. The safety and efficacy of this device has been demonstrated in Western countries, but studies with S-ICD ...
Nobuhiro Nishii, MD   +10 more
doaj   +1 more source

A novel screening test for inappropriate shocks due to myopotentials from the subcutaneous implantable cardioverter–defibrillatorKey Findings

open access: yesHeart Rhythm O2, 2020
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is effective in preventing sudden cardiac death. Compared with transvenous ICDs, S-ICDs have a lower rate of inappropriate shocks (IASs) for supraventricular arrhythmias, but ...
Yuji Ishida, MD, PhD   +10 more
doaj   +1 more source

Implantable Cardioverter‐Defibrillators in Children: A 14‐Year Population‐Based Study

open access: yesJournal of Arrhythmia, Volume 42, Issue 2, April 2026.
Nationwide pediatric ICD cohort from Slovakia illustrating incidence, indications, shock outcomes, and device‐related adverse events, highlighting the predominance of secondary prevention and the clinical burden of inappropriate shocks and major complications.
Marko Bjeloševič   +4 more
wiley   +1 more source

Hyperkalemia-Induced T Wave Oversensing in an Implantable Cardioverter Defibrillator

open access: yesCureus
A 66-year-old female with end-stage renal disease and heart failure with reduced ejection fraction, status post implantable cardioverter defibrillator (ICD) presented to the emergency department with dizziness and fatigue. An electrocardiogram showed sinus rhythm, complete atrioventricular block, and ventricular paced rhythm at 30 beats per minute (bpm)
Gonzalez, Ariel   +3 more
openaire   +2 more sources

Does an Implantable Cardiac Monitor Always Tell the Truth? A Case of an Underestimated Prolonged Pause Episode

open access: yesJournal of Arrhythmia, Volume 42, Issue 2, April 2026.
A graphical summary of the mechanism underlying the underestimation of a prolonged pause episode by an implantable cardiac monitor (ICM). This case illustrates that ICM episode summaries may underestimate clinically significant pauses, underscoring the importance of electrogram review and remote monitoring for accurate diagnosis.
Ryo Takahashi   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy